Woodmont Investment Counsel’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-62,818
Closed -$1.75M 257
2022
Q4
$1.75M Sell
62,818
-7,246
-10% -$185K 0.2% 97
2022
Q3
$1.64M Sell
70,064
-8,125
-10% -$245K 0.2% 96
2022
Q2
$2.64M Sell
78,189
-2,984
-4% -$105K 0.33% 75
2022
Q1
$2.83M Buy
81,173
+5,871
+8% +$201K 0.33% 77
2021
Q4
$2.29M Buy
75,302
+3,053
+4% +$99.4K 0.29% 78
2021
Q3
$2.37M Buy
72,249
+37,999
+111% +$1.22M 0.34% 70
2021
Q2
$1.04M Buy
+34,250
New +$1.13M 0.16% 106

Other funds holding OGN

Woodmont Investment Counsel's OGN Position: Q1 2023 in Review

Woodmont Investment Counsel sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 62,818 shares — an estimated $1.75M sold.

Woodmont Investment Counsel first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $2.83M in Q1 2022. 768 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Woodmont Investment Counsel reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Woodmont Investment Counsel sold 62,818 Organon & Co shares in Q1 2023, an estimated $1.75M.
  • Woodmont Investment Counsel first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Woodmont Investment Counsel's Organon & Co position peaked at $2.83M in Q1 2022.
  • 768 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Woodmont Investment Counsel's 13F filing for Q1 2023, filed 9 May 2023.